bucladesine and pentoxifylline
bucladesine has been researched along with pentoxifylline in 43 studies
Research
Studies (43)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (16.28) | 18.7374 |
1990's | 20 (46.51) | 18.2507 |
2000's | 10 (23.26) | 29.6817 |
2010's | 6 (13.95) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Baik, KU; Cho, JY; Park, MH; Yoo, ES; Yoshikawa, K | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Cardinali, DP | 1 |
Aparicio, NJ; De Turner, E; Schwarzstein, L; Turner, D | 1 |
de Prost, D; Hakim, J; Ollivier, V | 2 |
Bang, YJ; Danielpour, D; Kim, KY; Kim, SJ; Myers, CE; O'Reilly, MA; Trepel, JB | 1 |
Crowley, J; Harada, H; Hatherill, JR; Hoffmann, H; Ishizaka, A; Raffin, TA; Yonemaru, M; Zheng, H | 1 |
Chan, JC; Crowley, JJ; Raffin, TA; Zheng, H | 1 |
Beutler, B; Han, J; Huez, G | 1 |
Chan, JC; Crowley, JJ; Hatherill, JR; Hoffmann, H; Ishizaka, A; Raffin, TA; Zheng, H | 1 |
Kunkel, SL; Larrick, J; Lynch, JP; Remick, DG; Spengler, RN; Strieter, RM; Ward, PA | 1 |
Comte, J; Gautheron, DC; Godinot, C; Meister, R | 1 |
Cohen, HJ; Crawford, J; Currie, MS; Rao, KM | 1 |
Baggetto, LG; Comte, J; Gautheron, DC; Godinot, C; Meister, R | 1 |
Herman, G; Mauduit, P; Rossignol, B | 1 |
Deguine, V; Dosne, AM; Greenberg, SM; Kerbiriou-Nabias, D; Lecoq, D; Meyer, D | 1 |
Hatano, Y; Hirokawa, M; Kitabayashi, A; Kuroki, J; Lee, M; Miura, AB; Niitsu, H | 1 |
Edwards, MJ; Knott, AW; Miller, FN; Nakagawa, K | 1 |
Chiang, CH; Hsu, K; Shen, CY; Wang, D | 1 |
Cash, E; Fleischer, B; Rott, O | 1 |
Hara, Y; Komuro, Y; Oh-ishi, S; Utsunomiya, I; Yamamoto, T | 1 |
Babin-Chevaye, C; Franzini, E; Hakim, J; Marquetty, C; Pasquier, C; Sellak, H | 1 |
Ernst, M; Funk, JO; Schönharting, MM; Zabel, P | 1 |
Chiang, CH; Hsu, CS; Hsu, K; Huang, KL; Wang, D | 1 |
Badovinac, V; Mostarica Stojković, M; Stosić-Grujicić, S; Trajković, V | 1 |
Isbrucker, R; Peterson, TC; Slysz, G | 1 |
Bal, V; Durdik, JM; George, A; Gupta, M; Rath, S; Sen, R | 1 |
Buratti, T; Dunzendorfer, S; Herold, M; Kähler, CM; Reinisch, N; Schratzberger, P; Tilg, H; Wiedermann, CJ | 1 |
Dunzendorfer, S; Meierhofer, C; Wiedermann, CJ; Xu, Q | 1 |
Beshay, E; Croze, F; Prud'homme, GJ | 1 |
Diab-Assef, M; Duclos, B; Ezenfis, J; Foltzer-Jourdainne, C; Kedinger, M; Reimund, JM | 1 |
Aitken, RJ; Jones, RC; Murdoch, RN; Wade, MA | 1 |
Hareng, L; Hartung, T; Meergans, T; Volk, HD; von Aulock, S | 1 |
Clulow, J; Jones, RC; Man, SY | 1 |
Buffone, MG; Calamera, JC; Doncel, GF; Marín Briggiler, CI; Vazquez-Levin, MH | 1 |
Buffone, MG; Calamera, JC; Doncel, GF; Verstraeten, SV | 1 |
Boszczyk, A; Dziunycz, P; Grzela, T; Lazarczyk, M; Lazarczyk, MA; Milewski, L; Niderla, J; Samaha, R | 1 |
Cohen, JD; Gallegos, AC; Lau, SS; Mastrandrea, NJ; Monks, TJ; Tham, KY | 1 |
Azami, K; Beyer, C; Ghadiri, T; Gholizadeh, S; Hosseini-Zare, MS; Mobasseri, M; Salehi, F; Seyedi, SY; Sharifzadeh, M | 1 |
Chaube, SK; Premkumar, KV | 1 |
Aghajani, H; Hosseini-Zare, MS; Salehi, F; Seyedi, SY; Sharifzadeh, M | 1 |
Other Studies
43 other study(ies) available for bucladesine and pentoxifylline
Article | Year |
---|---|
In vitro antiinflammatory effects of neolignan woorenosides from the rhizomes of Coptis japonica.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Interleukin-2; Lignans; Lymphocytes; Macrophages; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Plants, Medicinal; Spleen; Tumor Necrosis Factor-alpha | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effects of pentoxifylline and theophylline on neurotransmitter uptake and release by synaptosome-rich homogenates of the rat hypothalamus.
Topics: Animals; Bucladesine; Dopamine; Glutamates; Hypothalamus; Male; Neurotransmitter Agents; Norepinephrine; Pentoxifylline; Potassium; Rats; Serotonin; Synaptosomes; Theobromine; Theophylline; Xanthines | 1977 |
Effect of two phosphodiesterase inhibitors, cyclic adenosine 3':5'-monophosphate, and a beta-blocking agent on human sperm motility.
Topics: Adolescent; Adult; Bucladesine; Caffeine; Humans; Male; Pentoxifylline; Propranolol; Sperm Motility; Theobromine; Time Factors | 1978 |
[Inhibition by pentoxifylline of procoagulant activity produced by endotoxin-active monocytes].
Topics: 1-Methyl-3-isobutylxanthine; Blood Coagulation; Bucladesine; Cyclic AMP; Dose-Response Relationship, Drug; Endotoxins; Humans; In Vitro Techniques; Monocytes; Pentoxifylline; Thromboplastin | 1992 |
Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.
Topics: 1-Methyl-3-isobutylxanthine; Aprotinin; Blotting, Northern; Bucladesine; Cell Division; Cell Line; Cyclic AMP; Cycloheximide; Dactinomycin; DNA Replication; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Leupeptins; Male; Pentoxifylline; Phenylmethylsulfonyl Fluoride; Prostatic Neoplasms; RNA, Neoplasm; Theophylline; Transcription, Genetic; Transforming Growth Factor beta; Tumor Cells, Cultured | 1992 |
Pentoxifylline inhibition of procoagulant activity generated by activated mononuclear phagocytes.
Topics: 1-Methyl-3-isobutylxanthine; Blood Coagulation Factors; Bucladesine; Cyclic AMP; Humans; Lipopolysaccharides; Monocytes; Pentoxifylline; Tumor Cells, Cultured | 1990 |
Early post-treatment with pentoxifylline or dibutyryl cAMP attenuates Escherichia coli-induced acute lung injury in guinea pigs.
Topics: Animals; Blood Pressure; Bronchoalveolar Lavage Fluid; Bucladesine; Endotoxins; Escherichia coli; Escherichia coli Infections; Guinea Pigs; Leukocyte Count; Luminescent Measurements; Lung Diseases; Neutrophils; Organ Size; Pentoxifylline; Pulmonary Edema; Serum Albumin | 1991 |
Attenuation of LPS-induced neutrophil thromboxane b2 release and chemiluminescence.
Topics: Adenosine; Bucladesine; Humans; In Vitro Techniques; Lipopolysaccharides; Luminescent Measurements; Neutrophils; Pentoxifylline; Terbutaline; Tetradecanoylphorbol Acetate; Thromboxane B2; Tumor Necrosis Factor-alpha | 1991 |
Interactive effects of the tumor necrosis factor promoter and 3'-untranslated regions.
Topics: Base Sequence; Bucladesine; Cells, Cultured; Chloramphenicol O-Acetyltransferase; Gene Expression Regulation; Lipopolysaccharides; Pentoxifylline; Promoter Regions, Genetic; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; RNA, Messenger; Suppression, Genetic; Transcription, Genetic; Transfection; Tumor Necrosis Factor-alpha | 1991 |
Attenuation of tumor necrosis factor-induced endothelial cell cytotoxicity and neutrophil chemiluminescence.
Topics: Aminophylline; Animals; Bucladesine; Caffeine; Cattle; Cell Survival; Cells, Cultured; Chromium Radioisotopes; Colforsin; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Neutrophils; Pentoxifylline; Tumor Necrosis Factor-alpha | 1990 |
Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Biological Assay; Bucladesine; Cyclic AMP; Dinoprostone; Lipopolysaccharides; Mice; Pentoxifylline; Theobromine; Theophylline; Tumor Necrosis Factor-alpha | 1988 |
Cyclic GMP, cyclic AMP, glucose at birth, and maturation of rat liver mitochondria.
Topics: Adenosine Diphosphate; Animals; Animals, Newborn; Bucladesine; Cyclic AMP; Cyclic GMP; Glucose; Kinetics; Liver; Mitochondria, Liver; Nitroprusside; Oxidation-Reduction; Pentoxifylline; Rats; Rats, Inbred Strains | 1988 |
Actin depolymerization and inhibition of capping induced by pentoxifylline in human lymphocytes and neutrophils.
Topics: Actins; Bucladesine; Humans; Immunologic Capping; Lymphocytes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentoxifylline; Pertussis Toxin; Polymers; Theobromine; Virulence Factors, Bordetella | 1988 |
Reversal of glucose-induced inhibition of newborn rat liver mitochondrial maturation by administration of alkylxanthines at birth.
Topics: Animals; Animals, Newborn; Bucladesine; Butyrates; Cyclic AMP; Glucose; Liver; Mitochondria, Liver; Oxidation-Reduction; Oxygen Consumption; Pentoxifylline; Rats; Rats, Inbred Strains; Succinates; Succinic Acid; Theobromine; Xanthines | 1986 |
Protein secretion induced by isoproterenol or pentoxifylline in lacrimal gland: Ca2+ effects.
Topics: Animals; Bucladesine; Calcium; Carbachol; Cyclic AMP; Isoproterenol; Kinetics; Lacrimal Apparatus; Male; Papaverine; Pentoxifylline; Proteins; Rats; Rats, Inbred Strains; Theobromine | 1984 |
Cyclic adenosine monophosphate-dependent mechanisms induce von Willebrand factor expression in the Dami megakaryoblastic cell line.
Topics: 1-Methyl-3-isobutylxanthine; Aneuploidy; Bucladesine; Colforsin; Cyclic AMP; Fluorescent Antibody Technique; Gene Expression Regulation, Leukemic; Humans; L-Lactate Dehydrogenase; Leukemia, Megakaryoblastic, Acute; Megakaryocytes; Neoplasm Proteins; Pentoxifylline; Platelet Membrane Glycoproteins; Tumor Cells, Cultured; von Willebrand Factor | 1995 |
Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-alpha production.
Topics: Antibodies, Monoclonal; Bucladesine; Burkitt Lymphoma; Cyclic AMP; Cytotoxicity, Immunologic; Gene Expression Regulation; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Lymphocyte Activation; Pentoxifylline; Recombinant Proteins; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1995 |
Pentoxifylline inhibits FMLP-induced macromolecular leakage.
Topics: Animals; Bucladesine; Capillary Permeability; Cell Adhesion; Leukocytes; Macromolecular Substances; Male; Microcirculation; N-Formylmethionine Leucyl-Phenylalanine; Pentoxifylline; Rats; Rats, Sprague-Dawley; Serum Albumin, Bovine | 1995 |
Protamine-induced acute lung injury and the protective effect of agents that increase cAMP.
Topics: Aminophylline; Animals; Blood Pressure; Bucladesine; Cyclic AMP; Lung; Male; Organ Size; Pentoxifylline; Protamines; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 1993 |
Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats.
Topics: Animals; Bucladesine; Encephalomyelitis, Autoimmune, Experimental; Female; Immunosuppressive Agents; Interleukin-2; Interleukin-4; Lymphocyte Activation; Lymphokines; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Lew; T-Lymphocytes, Helper-Inducer; Tumor Necrosis Factor-alpha | 1993 |
Effects of prostaglandins and cyclic AMP on cytokine production in rat leukocytes.
Topics: Alprostadil; Animals; Bucladesine; Carrageenan; Cell Line; Chemokine CXCL1; Chemokines, CXC; Chemotactic Factors; Cyclic AMP; Cytokines; Dinoprostone; Epoprostenol; Excipients; Female; Growth Substances; Intercellular Signaling Peptides and Proteins; Leukocytes; Male; Mice; Mice, Inbred C3H; Oxytocics; Pentoxifylline; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Pleurisy; Rats; Rats, Sprague-Dawley | 1996 |
Inhibition of human neutrophil binding to hydrogen peroxide-treated endothelial cells by cAMP and hydroxyl radical scavengers.
Topics: 1-Methyl-3-isobutylxanthine; Analysis of Variance; Bucladesine; Cell Adhesion; Cells, Cultured; Cyclic AMP; Deferoxamine; Endothelium, Vascular; Free Radical Scavengers; Glutathione; Humans; Hydrogen Peroxide; Hydroxyl Radical; Hypoxanthine; Isoproterenol; Neutrophils; Pentoxifylline; Tetradecanoylphorbol Acetate; Thrombin; Transferrin; Umbilical Veins; Xanthine Oxidase | 1996 |
Pentoxifylline exerts synergistic immunomodulatory effects in combination with dexamethasone or cyclosporin A.
Topics: Adjuvants, Immunologic; Bucladesine; Cells, Cultured; Cyclic AMP; Cyclosporine; Cytokines; Dexamethasone; Drug Combinations; Humans; Lymphocyte Activation; Pentoxifylline; Receptors, Interleukin-2 | 1995 |
Dibutyryl cAMP prevents increased vascular permeability caused by air embolism in isolated rat lungs.
Topics: Aerospace Medicine; Aminophylline; Animals; Bronchodilator Agents; Bucladesine; Capillary Permeability; Drug Evaluation, Preclinical; Embolism, Air; Extravehicular Activity; In Vitro Techniques; Lung; Male; Pentoxifylline; Pulmonary Wedge Pressure; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Time Factors; Vasodilator Agents | 1997 |
Pentoxifylline potentiates nitric oxide production and growth suppression in interferon-gamma-treated L929 fibroblasts.
Topics: Animals; Bucladesine; Cell Division; Cell Line; Cyclic AMP; Drug Synergism; Interferon-gamma; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroprusside; Pentoxifylline; Phosphodiesterase Inhibitors; Recombinant Proteins | 1998 |
The inhibitory effect of ursodeoxycholic acid and pentoxifylline on platelet derived growth factor-stimulated proliferation is distinct from an effect by cyclic AMP.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antimetabolites; Bucladesine; Cell Division; Cells, Cultured; Cholagogues and Choleretics; Cyclic AMP; Dideoxyadenosine; Drug Interactions; Enzyme Inhibitors; Fibroblasts; Humans; Pentoxifylline; Platelet-Derived Growth Factor; Stimulation, Chemical; Taurochenodeoxycholic Acid; Tetrazolium Salts; Thiazoles; Ursodeoxycholic Acid | 1998 |
Presence of pentoxifylline during T cell priming increases clonal frequencies in secondary proliferative responses and inhibits apoptosis.
Topics: Adjuvants, Immunologic; Apoptosis; Biomarkers; Bucladesine; Clone Cells; Humans; Immunization, Secondary; Immunologic Memory; Immunosuppressive Agents; Interleukin-2; Isoantigens; Lymphocyte Activation; Lymphocyte Count; Pentoxifylline; Receptors, Interleukin-2; T-Lymphocytes; Time Factors | 1999 |
Mediator-dependent effects of pentoxifylline on endothelium for transmigration of neutrophils.
Topics: 1-Methyl-3-isobutylxanthine; Adjuvants, Immunologic; Bucladesine; Cell Adhesion; Cell Movement; Endothelium, Vascular; Granulocyte Colony-Stimulating Factor; Humans; Interleukin-1; Interleukin-8; Lipopolysaccharides; Neutrophils; Pentoxifylline; Phosphodiesterase Inhibitors; Theophylline; Tumor Necrosis Factor-alpha | 1999 |
Pentoxifylline-augmented antiproliferative effects of adrenomedullin on vascular smooth muscle cells.
Topics: Adrenomedullin; Animals; Aorta; Bucladesine; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Cell Division; Cells, Cultured; Cyclic AMP; Intracellular Fluid; Miotics; Muscle, Smooth, Vascular; Pentoxifylline; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 2000 |
The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Autoimmune Diseases; Bucladesine; Cells, Cultured; Colforsin; Cyclic AMP; Diabetes Mellitus, Type 1; Dibutyryl Cyclic GMP; Disease Models, Animal; Drug Evaluation, Preclinical; Enterotoxins; Enzyme Induction; Female; Interferon-gamma; Interleukin-12; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred NOD; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Pentoxifylline; Phosphodiesterase Inhibitors; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rolipram; Tumor Necrosis Factor-alpha | 2001 |
The phosphodiesterase inhibitor, pentoxifylline, alters rat intestinal epithelial cell proliferation via changes in the expression of transforming growth factors.
Topics: Animals; Bucladesine; Cell Division; Cell Line; Cyclic AMP; Epithelial Cells; Intestinal Mucosa; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; RNA, Messenger; Transforming Growth Factors | 2002 |
Motility activation and second messenger signalling in spermatozoa from rat cauda epididymidis.
Topics: Animals; Bucladesine; Calcium; Cell Culture Techniques; Culture Media; Cyclic AMP; Epididymis; Male; Models, Biological; Pentoxifylline; Rats; Rats, Wistar; Second Messenger Systems; Sperm Motility; Spermatozoa; Sucrose | 2003 |
Cyclic AMP increases endogenous granulocyte colony-stimulating factor formation in monocytes and THP-1 macrophages despite attenuated TNF-alpha formation.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Bucladesine; Cell Line; Colforsin; Cyclic AMP; Dinoprostone; Female; Granulocyte Colony-Stimulating Factor; Humans; In Vitro Techniques; Lipopolysaccharides; Macrophages; Monocytes; Naphthyridines; Pentoxifylline; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Tumor Necrosis Factor-alpha; Up-Regulation | 2003 |
Signal transduction in the ductuli efferentes testis of the rat: inhibition of fluid reabsorption by cyclic adenosine 3', 5'-monophosphate.
Topics: Absorption; Animals; Body Fluids; Bucladesine; Cyclic AMP; Dibutyryl Cyclic GMP; Ejaculatory Ducts; In Vitro Techniques; Male; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Signal Transduction; Testis | 2003 |
Human sperm subpopulations: relationship between functional quality and protein tyrosine phosphorylation.
Topics: Bucladesine; Centrifugation, Density Gradient; Colloids; Humans; Male; Motion; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphorylation; Povidone; Reference Values; Silicon Dioxide; Sperm Capacitation; Sperm Motility; Spermatozoa; Tyrosine | 2004 |
Capacitation-associated protein tyrosine phosphorylation and membrane fluidity changes are impaired in the spermatozoa of asthenozoospermic patients.
Topics: Adult; Analysis of Variance; Blotting, Western; Bucladesine; Case-Control Studies; Cells, Cultured; Fluorescent Antibody Technique, Indirect; Humans; Image Processing, Computer-Assisted; Male; Membrane Fluidity; Microscopy, Fluorescence; Oligospermia; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphorylation; Phosphotyrosine; Sperm Capacitation; Sperm Motility; Spermatozoa; Tyrosine | 2005 |
Influence of pentoxifylline on natural cytotoxicity and expression of granzymes and PI-9, a specific granzyme B inhibitor.
Topics: Bucladesine; Granzymes; Humans; K562 Cells; Leukocytes, Mononuclear; Pentoxifylline; Pertussis Toxin; Phosphodiesterase Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors; Serpins | 2006 |
cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Topics: Animals; Benzenesulfonates; Bucladesine; Carcinoma, Renal Cell; Cell Line; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Cytosol; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Glutathione; Humans; Hydroquinones; Kidney Neoplasms; Male; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Niacinamide; Pentoxifylline; Phenylurea Compounds; Phosphodiesterase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Pyridines; Rats; RNA, Small Interfering; Signal Transduction; Sorafenib; Theophylline; Tuberous Sclerosis; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2011 |
Effects of pentoxifylline and H-89 on epileptogenic activity of bucladesine in pentylenetetrazol-treated mice.
Topics: Animals; Bucladesine; Dose-Response Relationship, Drug; Drug Interactions; Isoquinolines; Male; Mice; Pentoxifylline; Pentylenetetrazole; Phosphodiesterase Inhibitors; Protein Kinase Inhibitors; Seizures; Sulfonamides | 2011 |
Increased level of reactive oxygen species persuades postovulatory aging-mediated spontaneous egg activation in rat eggs cultured in vitro.
Topics: Animals; Bucladesine; Butylated Hydroxyanisole; Calcium-Calmodulin-Dependent Protein Kinase Type 2; CDC2 Protein Kinase; Cellular Senescence; Cyclin B1; Cyclin-Dependent Kinases; F-Box Proteins; Female; Hydrogen Peroxide; Luteal Phase; Membrane Potential, Mitochondrial; Mitochondria; Oocytes; Pentoxifylline; Phosphorylation; Rats, Inbred Strains; Reactive Oxygen Species | 2016 |
Effect of bucladesine, pentoxifylline, and H-89 as cyclic adenosine monophosphate analog, phosphodiesterase, and protein kinase A inhibitor on acute pain.
Topics: Acute Pain; Animals; Bucladesine; Cyclic AMP; Dose-Response Relationship, Drug; Isoquinolines; Male; Mice; Pain Measurement; Pentoxifylline; Phosphodiesterase Inhibitors; Sulfonamides; Treatment Outcome | 2017 |